Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2161–2184 of 6,310 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolism and Nutrition Disorders Clear all

Conditions: Obesity
Interventions: CHild Inhibitory Control (CHIC) Play, Attention control; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 4 Years to 6 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: San Diego, California

Conditions: Obesity
Interventions: Healthy Weight for Living for Hispanics; Behavioral
Lead sponsor: Tufts University; Other
Eligibility: 50 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Overweight
Interventions: LY3437943, Ethinyl Estradiol, Drospirenone; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 40 Years to 60 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: South Miami, Florida • San Antonio, Texas

Conditions: Obesity
Interventions: BTA, Placebo (normal saline); Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, Diabetes, Peripheral Vascular Disease
Interventions: Prevena vac; Device
Lead sponsor: Dr. Jean E. Starr, MD; Other
Eligibility: 18 Years and older
Enrollment: 276 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obesity
Interventions: Reduced fat diet, Reduced carbohydrate diet, Drug: f-18 fallypride, fMRI, PET; Other · Drug · Device
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Overweight, Obesity
Interventions: Standard, Social support-enhanced, Fitbit Zip, Digital body weight scale; Behavioral · Device
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Hyperglycemia, Diabetes, and Obesity
Interventions: Resistant Starch, Control; Dietary Supplement
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 29 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Weight Loss
Interventions: Bite Counter; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Sickle Cell Disease, Anemia, Sickle Cell, Anemia, Hemolytic, Congenital, Respiratory Tract Diseases, Respiration Disorders, Acute Chest Syndrome, Lung Diseases, Asthma, Respiratory Tract Infections, Nutrition Disorders, Deficiency Diseases Vitamin, Vitamin D Deficiency
Interventions: Daily oral vitamin D3, 3,333 IU, Monthly oral vitamin D3, 100,000 IU, Placebo oral tablet; Drug
Lead sponsor: Columbia University; Other
Eligibility: 3 Years to 20 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: Project Health, Educational Video Control; Behavioral · Other
Lead sponsor: University of Houston; Other
Eligibility: 18 Years to 25 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Emotional Disturbances, Depression, Pregnancy Late, Post-Partum Depression, Anxiety, Nutritional Deficiency
Interventions: COPE-P; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 299 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 3
States / cities: The Bronx, New York • Columbus, Ohio

Conditions: Obesity
Interventions: Continuous Caloric Restriction versus Intermittent Caloric Restriction on Fat Loss; Behavioral
Lead sponsor: Coastal Carolina University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Conway, South Carolina

Conditions: Obesity, Obesity; Drug, Lifestyle, Healthy
Interventions: Online Lifestyle Behavioral Therapy, Phentermine Hydrochloride 8 MG; Behavioral · Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 70 Years
Enrollment: 870 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Los Angeles, California • Saint Louis Park, Minnesota • Winston-Salem, North Carolina + 1 more

Conditions: Obesity, Weight Loss, Body Weight, Hepatocellular Carcinoma, HCC, Hepatitis C, Cirrhosis
Interventions: Embospheres Microspheres; Device
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity
Interventions: glucose, fructose, saline; Dietary Supplement
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2015
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obesity
Interventions: Questionnaire; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 30 Years to 55 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2021
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: CBT, educational; Behavioral · Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity, Overweight, Weight Loss
Interventions: Physician Counseling, Health Educator, Phone Counseling, Health promotion materials on physical activity and nutrition; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 11 Years to 13 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Obesity
Interventions: More-Intensive, Less-Intensive; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Hypogonadism, Hypogonadotropic, Obesity
Interventions: anastrozole (1 mg/day), Placebo; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 40 Years to 65 Years · Male only
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
Interventions: ALN-CIDEB, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Miami, Florida • Marrero, Louisiana • Metairie, Louisiana + 1 more

Conditions: Obesity
Interventions: Vitamin D3; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 12 Years to 18 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: AIDS Wasting Syndrome
Interventions: Testosterone; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

Promoting Child Inhibitory Control Skills Around Food

Development of Novel Behavioral Intervention for Sustainable Weight Loss in Hispanic Adults With Obesity

A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese

Effects of Gastric Antral Botulinum Toxin Injections in Obese Subjects

Effects of Prevena Therapy on Obese and or Diabetic Patients With Surgical Groin Sites

Reduced Carbohydrate Versus Fat in Obese Subjects

Nutrition, Exercise, and Technology for Weight Loss

Effects of Resistant Starch in a Beverage on Post-prandial Glycemic and Insulinemic Responses

Assessing the Bite Counter

Daily Vitamin D for Sickle-cell Respiratory Complications

Project Health Intervention Among Latinx Adults in Primary Care

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women

The Effects of Continuous vs. Intermittent Caloric Restriction on Fat Los

Long-term Effectiveness of the Antiobesity Medication Phentermine

Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation

Hypothalamic Functional Magnetic Resonance Imaging (fMRI) Response to Nutrients

Prevalence of Endometrial Abnormalities In Obese Women

Cognitive Behavioral Therapy for Obesity

PACE-PC: Primary Care Management of Adolescent Obesity

Delivering an Evidence-Based Lifestyle Intervention Via the Internet: A Randomized Controlled Study

Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism

Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Effect of Vitamin D3 Supplementation on Insulin Resistance and Cardiovascular Risk Factors in Obese Adolescents

AIDS Wasting in Women: Anabolic Effects of Testosterone